A significant advance in cancer investigation is occurring with the use of mini-antibodies to reactivate mutated p53. This essential tumor suppressor protein is frequently lost in many types of tumors, leading https://hylistings.com/story23341041/nanobodies-reactivate-the-p53-protein-new-potential-pathway-for-tumor-treatment